In Fig. 2A-B, the expression levels of CDCA2, CDCA3, CDCA4, CDCA5, CDCA7, and CDCA8 were compared between normal and primary GBM tumor samples using TCGA data via the UALCAN and GEPIA2 platforms. This evidence concerns the gene CDCA5 and glioblastoma.